In the attempt to find a wider panel of biomarkers for treatment response in ESCC, a recent study has evaluated the expression level of 16 proteins, including p53, in ESCC treated with CCRT (concurrent chemoradiation therapy) [69]. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.